Lipocine
LPCN
#9833
Rank
NZ$77.56 M
Marketcap
NZ$13.97
Share price
6.37%
Change (1 day)
59.81%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: NZ$77.56 Million

As of January 2026 Lipocine has a market cap of NZ$77.56 Million. This makes Lipocine the world's 9833th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$77.56 M54.71%
2025NZ$50.13 M11.08%
2024NZ$45.13 M92.47%
2023NZ$23.45 M-57.71%
2022NZ$55.45 M-56.71%
2021NZ$0.12 B3.47%
2020NZ$0.12 B475.4%
2019NZ$21.51 M-48.91%
2018NZ$42.11 M-58.98%
2017NZ$0.10 B5.83%
2016NZ$97.01 M-71.85%
2015NZ$0.34 B301.28%
2014NZ$85.89 M-32.46%
2013NZ$0.12 B

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of Lipocine was reported to be:

NZ$77.56 Million
by Nasdaq info icon info icon
NZ$77.56 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
NZ$75.27 B 96,940.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$17.07 B 21,916.80%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
NZ$18.18 M-76.56%๐Ÿ‡บ๐Ÿ‡ธ USA